PCVX · Vaxcyte, Inc. · Investor Relations
$56.48
+0.43 (+0.77%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$8.36B
Shares
148.81M
Volume · Oct 2
2.4M
Avg daily vol (3M)
1.15M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-09 | Cantor Global Healthcare Conference | Conference |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-06-15 | Vaxcyte, Inc. Virtual Stockholders Meeting | Shareholder meeting |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-12 | BofA Securities 2026 Health Care Conference | Conference |
| 2026-04-14 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-02-24 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-06-12 | Vaxcyte, Inc. Virtual Stockholders Meeting | Shareholder meeting |
| 2025-03-31 | Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call | Earnings call |
| 2025-02-25 | Vaxcyte 4Q & FY 2024 Financial Results and Business Update | Event |
| 2024-09-03 | Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call | Earnings call |
| 2023-04-17 | Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call | Earnings call |
| 2022-10-24 | Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call | Event |
Source: https://investors.vaxcyte.com/